Lucknow (Uttar Pradesh) [India], June 1 (ANI): A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his body after receiving the first dose of Covishield.
URL copied
UP man lodges complaint against SII CEO, ICMR chief; says no antibodies developed post vaccine
A man in Uttar Pradesh s Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his body after receiving the first dose of Covishield.
Pratap Chandra, a resident of Lucknow, stated that after listening to a press briefing of ICMR where it was mentioned that antibodies in sufficient quantities are formed in the body against the virus after taking the first dose, he got an antibody test to determine the level of antibodies formed in his body.
Others named in the complaint are DCGA director, Joint Secretary of Health Ministry Luv Agarwal, ICMR director Balaram Bhargava, National Health Mission director Aparna Upadhyay, among others.
Serum Institute Disassociates From Executive s Remarks On Vaccination Serum Institute Disassociates From Executive s Remarks On Vaccination Serum Institute of India clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company,
Updated: May 23, 2021 7:25 pm IST
Serum Institute has distanced itself from a controversial remark made by its official
The Serum Institute has distanced itself from its executive director s statement that the Centre began the COVID-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is not the view of the company .
In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said.